Advanced Cell Diagnostics

Health diagnostics life sciences platform

ACD shortens the path to personalized medicine by unlocking the power of RNA biomarkers. Advanced Cell Diagnostics, Inc. (ACD) is a leader in the emerging field of molecular pathology, developing cell- and tissue-based diagnostic tests for personalized medicine. Based in the heart of Silicon Valley, ACD was founded and managed by experienced entrepreneurs in the life science industry. ACD’s products and services are based on its proprietary RNAscope® technology, the first multiplex fluorescent and chromogenic in situ hybridization platform capable of detecting and quantifying RNA biomarkers in situ at single molecule sensitivity.

Company Growth (employees)

Type

Private

Hayward, US

Founded

2006

Size (employees)

138 (est)+3%

Website

acdbio.com

Advanced Cell Diagnostics was founded in 2006 and is headquartered in Hayward, US

Key People at Advanced Cell Diagnostics

Yuling Luo

Founder, President & Chief Executive Officer

Xiao-Jun Ma

Chief Scientific Officer

Tony Lam

VP Regulatory Affairs and Quality Assurance

Evangeline Gonzalez

Chief Commercial Officer

Steve Chen

Founder, Chief Operating Officer

Christopher Bunker

Vice President, Business Development

Advanced Cell Diagnostics Office Locations

Advanced Cell Diagnostics has an office in Hayward

Hayward, US (HQ)

3960 Point Eden Way

Advanced Cell Diagnostics Data and Metrics

Summary Metrics

Founding Date	2006
Total Funding	$39.4 m
Latest funding size	$22 m
Time since last funding	about 2 years
Investors	Summit Partners, Kenson Ventures, Morningside Group, National Cancer Institute (NCI), Morningside Ventures, New Leaf Venture Partners